Bactiguard Holding AB (publ)

BACTI-B · Nasdaq Stockholm · Healthcare

15.40SEK −2.8%last day

Price as of 2 October 2026

The price over the past year, with dividends: −23.8%

Performance

1 month

−5.5%

1 year

−23.8%

3 years, per year

−38.0%

5 years, per year

−37.6%

Largest fall, 3 years

−87.2%

Below the peak now

−92.5%

Volatility, 1 year

60.0%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

1.7

Dividend yield

0.0%

Return on equity

−2.9%

Net margin

−4.3%

Market value

54 m USD

Quality, value and trend

Where Bactiguard Holding stands against every Nordic stock today. 100 is best.

Quality60

Profitability and a sound balance sheet over time. Better than 60% of Nordic stocks.

Value35

The price measured against earnings, assets and cash flow. Better than 35% of Nordic stocks.

Trend32

The price development over the past year. Better than 32% of Nordic stocks.

Combined33

Quality, value and trend together. Better than 33% of Nordic stocks.

About Bactiguard Holding

Bactiguard Holding AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 160 employees.

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for acute, chronic, and infected wounds; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis